TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›BZ›Financials
Annual statements · SEC XBRL · FY2021 – FY2025

Kanzhun Ltd (BZ) financials

Income statement

Kanzhun Ltd (BZ) income statement, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$668M$654M$838M$1.01B$1.18B
Revenue growth—-2.1%28.2%20.2%17.3%
Operating income-$163M-$18.8M$81.8M$161M$352M
Operating margin-24.3%-2.9%9.8%15.9%29.8%
Net income-$168M$15.5M$155M$215M$391M
Net margin-25.1%2.4%18.5%21.3%33.1%
EPS (diluted)-$0.37$0.02$0.17$0.24$0.42

Cash flow

Kanzhun Ltd (BZ) cash flow, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Operating cash flow$258M$145M$429M$485M$651M
Capital expenditures$40.8M$49.3M$135M$117M$17.0M
Free cash flow$217M$96.1M$295M$368M$634M
Share buybacks$1.82M—$10.1M$226M$20.4M
Dividends paid——$79.3M—$79.1M

Balance sheet

Kanzhun Ltd (BZ) balance sheet, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Cash & equivalents$1.78B$1.41B$348M$350M$587M
Total assets$2.14B$2.15B$2.53B$2.65B$3.51B
Total liabilities$466M$462M$635M$596M$642M
Shareholders' equity$1.67B$1.69B$1.89B$2.04B$2.86B
Retained earnings-$580M-$520M-$351M-$126M$175M
Shares (wtd avg diluted)529M912M903M909M927M

Every figure is extracted from Kanzhun Ltd’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Kanzhun Ltd's annual revenue?
Kanzhun Ltd (BZ) reported $1.18B of revenue for fiscal year 2025 — up 17.3% from $1.01B in FY2024, per its annual report filed with the SEC.
Is Kanzhun Ltd profitable?
Yes — BZ earned $391M of net income in FY2025, a 33.1% net margin, per SEC filings.
What is Kanzhun Ltd's free cash flow?
$634M in FY2025 (operating cash flow $651M minus $17.0M of capital expenditures), from the SEC cash-flow statement.
Does BZ pay a dividend?
Yes — Kanzhun Ltd paid $79.1M in cash dividends during FY2025, per its SEC cash-flow statement.
Full BZ analysis — verdict, score & filings →Is BZ a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.